IP Library Granted Patent US 8,936,806
Granted Patent B2
US 8,936,806 · App. 12/524,097 · Granted Jan 20, 2015

Periostin induces proliferation of cardiomyocytes and promotes cardiac regeneration

Inventor: Bernhard Kuhn (Brookline, MA)
Assignee: Children's Medical Center Corporation
C12N5/0657A61K38/1709C12N2501/585C12N2501/998
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,936,806
App. No.
12/524,097
Granted
Jan 20, 2015
Kind
B2
Abstract

The present invention provides compositions and methods for increasing proliferation, increasing cell cycle activity, and/or proliferation of postmitotic mammalian differentiated cardiomyocytes. The invention can be used to slow, reduce, or prevent the onset of cardiac damage caused by, for example, myocardial ischemia, hypoxia, stroke, or myocardial infarction in vivo. In addition, the methods and compositions of the invention can be used to enhance proliferation of differentiated cardiomyocytes in vitro and/or ex vivo, which can then be used in tissue grafting.

Claims (11)

1. A method of inducing division of post mitotic mononucleated cardiomyocytes, the method comprising administering a composition comprising periostin to a subject in an amount effective to stimulate division of the post-mitotic mononucleated cardiomyocytes.

2. The method of claim 1 , wherein the step of administering further comprises repairing heart tissue comprising the steps of:

identifying a subject in need of heart tissue repair, and

administering to the subject an effective amount of the composition, such that division of post mitotic mononucleated cardiomyocytes increases.

3. The method of claim 2 , wherein the step of administering further comprises delivering the composition to a target area of the heart tissue.

4. The method of claim 3 wherein the delivering is locally to the target area.

5. The method of claim 2 , wherein the administering is by parenteral administration.

6. The method of claim 2 , wherein the step of administering the composition further comprises delivering the periostin composition with a slow controlled release delivery system.

7. The method of claim 2 , wherein the step of administering the composition further comprises delivering the composition on a biodegradable biological scaffold.

8. The method of claim 2 , wherein the administering is by intravenous administration.

9. The method of claim 2 , wherein the administering is by catheter infusion.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 21, 2010
From: CHILDREN'S HOSPITAL (BOSTON)
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024564/0024 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2010
From: KUHN, BERNHARD
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 023924/0392 →
Continuity (2)
Provisional Application 60881938 · Jan 22, 2007
Related Publication 20100166827A1 · Jul 1, 2010